SCHEMBL19262425

SCHEMBL19262425

CC(C)CCOCNNc1nccc(N2CCC(c3ccccc3)CC2)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 13/20 0.50
ACACB O00763 4/20 0.37
OPRM1 P35372 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926573 0.79 GRM2 (0.48) GRM2ACACBOPRM1
SCHEMBL6928779 0.77 GRM2 (0.43) GRM2ACACBOPRM1
SCHEMBL19625664 0.76 OPRM1 (0.44) GRM2OPRM1
SCHEMBL746720 0.74 DHFR (0.48) GRM2
SCHEMBL746858 0.70 GRM2 (0.51) GRM2
SCHEMBL17557415 0.69 GRM2 (0.49) GRM2ACACBOPRM1
SCHEMBL16944207 0.67 GRM2 (1.00) GRM2
SCHEMBL17557414 0.67 GRM2 (0.45) GRM2ACACBOPRM1
SCHEMBL27849033 0.66 GRM2 (0.45) GRM2
SCHEMBL10819324 0.66 DHFR (0.48) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9737533-B2 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders Janssen Pharmaceuticals. Inc. (US) 2017-08-22 US disclosed